Endocrinology · Short-acting insulin
Insulin (Actrapid / Aspart)
Dose
DKA: 0.1 U/kg/h IV. HyperK: 10 U in 50 mL 50% dextrose IV over 15 min. SC sliding scale per local.
Indications
- • DKA
- • HHS
- • Hyperkalaemia
- • Hyperglycaemia
Dilution & preparation
50 U in 50 mL NS (1 U/mL) IV infusion
Use
DKA, HHS, hyperkalaemia, perioperative/critical illness hyperglycaemia.
Monitoring
Capillary glucose hourly, K⁺ 2-hourly, ketones in DKA.
Side effects
- • Hypoglycaemia
- • Hypokalaemia
- • Weight gain (chronic)
Always confirm dose against your local formulary / BNF before prescribing.
